A recent study demonstrated that streptozotocin- (STZ-) induced diabetes mice develop several changes in the bone marrow after 12 months, including increased numbers of inflammatory CCR2+ monocytes that can “home” to the target tissues of chronic diabetic complications, such as the retina and the kidney [34]. The gene discussed is CCR2; the disease is diabetes mellitus.